RADIATION RESEARCH is a prestigious journal published by the RADIATION RESEARCH SOC that serves as a vital resource for professionals and researchers in the fields of biophysics, radiation science, and radiology. Established in 1954, this journal has consistently advanced the study of radiation's effects on health and the environment, bridging fundamental and applied research. It boasts an impressive impact factor reflected in its quartile rankings, including Q2 in Biophysics and Q1 in Radiation, making it a highly regarded publication within its discipline. Researchers will find valuable insights through rigorous peer-reviewed articles that explore innovative methodologies and findings related to radiation exposure, imaging technologies, and the biological consequences of radiation. Although the journal does not currently offer open access, it remains a vital reference for academia and industry, fostering a deeper understanding of radiation sciences and their implications for future research and public health.

International Journal of Particle Therapy, an esteemed publication from the INT JOURNAL PARTICLE THERAPY, stands at the forefront of innovative research in the realms of particle therapy, radiology, and atomic physics. Established as an Open Access journal since 2015, it provides a platform for scholarly articles that drive the advancement of knowledge and practice in cancer treatment and radiation therapy. With an impact factor reflective of its rising stature, this journal has been categorized in the Q2 quartile for both Atomic and Molecular Physics and Radiology, Nuclear Medicine and Imaging as of 2023, illustrating its significant role in contributing to these vital fields. Researchers, professionals, and students alike will find the journal indispensable for accessing pioneering studies that explore the efficacy and application of particle therapy, ensuring that the latest advancements reach a broad audience. With a robust focus on bridging theoretical insights and clinical practices, the International Journal of Particle Therapy remains committed to enhancing patient outcomes and fostering collaboration among scientists worldwide.

Reports of Practical Oncology and Radiotherapy is a distinguished open-access journal dedicated to advancing the fields of oncology, radiotherapy, and cancer research. Published by VIA MEDICA since 2001, this journal serves as a critical platform for disseminating innovative research and practical findings that impact clinical practices and patient outcomes. With an emphasis on fostering collaboration and knowledge exchange among researchers, clinicians, and students, the journal has positioned itself within the Q3 and Q4 categories of renowned directories in oncology, radiology, and nuclear medicine as of 2023. Based in Gdansk, Poland, it provides unrestricted access to its articles, ensuring that crucial research reaches a wide audience. This dedication to open access reflects the journal's commitment to transparency and innovation in the fight against cancer, making it an invaluable resource in this vital field of study.

Zeitschrift für Medizinische Physik is a prominent academic journal dedicated to advancing the field of medical physics, published by ELSEVIER. With an ISSN of 0939-3889 and an E-ISSN of 1876-4436, this journal has transitioned to an Open Access model since 2022, ensuring that cutting-edge research is readily accessible to a global audience. Based in Germany at RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, the journal encompasses a wide array of topics related to medical physics, thereby facilitating interdisciplinary collaboration. Its impressive categorization includes Q3 in Biophysics and Q2 in both Radiological and Ultrasound Technology and Radiology, Nuclear Medicine and Imaging as of 2023, reflecting its significant contribution to the scientific community. In the Scopus rankings, it holds respectable positions in its categories: #143/333 in Radiology and Nuclear Medicine, #28/63 in Radiological and Ultrasound Technology, and #83/152 in Biophysics, demonstrating its influence and reach. The journal's focus is not only on publishing innovative research but also on fostering education and discussion among researchers, professionals, and students in medical physics. Zeitschrift für Medizinische Physik invites scholars at all levels to contribute and engage with the content that shapes the future of this vital field.

Practical Radiation Oncology is a premier journal published by Elsevier Science Inc., focusing on the critically important fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1879-8500, this journal serves as an essential resource for professionals and researchers dedicated to advancing the practice and research of radiation oncology. Established in 2011 and continuing through 2024, it has quickly gained recognition, achieving a prestigious Q2 ranking in Oncology and an exceptional Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. The journal, housed in New York, USA, provides a platform for innovative research and practical insights, aimed at enhancing therapeutic practices and improving patient outcomes. As part of its commitment to fostering scientific dialogue, it also features a range of articles, reviews, and clinical studies that cater to the diverse interests of its readers. Hard-copy availability combined with digital access ensures a broad reach for the latest advancements in the field.

International Journal of Radiation Oncology Biology Physics, published by Elsevier Science Inc, is a premier academic journal that has played a critical role in advancing the field of radiation oncology since its inception in 1975. With an impressive impact factor and recognition as a Q1 journal across multiple categories such as Cancer Research, Oncology, and Radiology, this journal serves as a vital resource for researchers, clinicians, and students dedicated to understanding and improving cancer treatment modalities. Its multifaceted scope encompasses original research, reviews, and innovative clinical studies, fostering a deeper understanding of the interplay between radiation, biology, and oncology. With a remarkable ranking in Scopus, including a top position in Radiation Physics and an elite percentile in Oncology, IJROBP remains at the forefront of scientific discovery and innovation in the management of cancer. A traditional subscription model ensures high-quality, peer-reviewed content, providing invaluable insights that continue to advance the standards of care and research in radiation oncology.

Journal of Radiotherapy in Practice is a peer-reviewed journal published by Cambridge University Press, focusing on the evolving field of radiotherapy and its application in clinical practice. With ISSN 1460-3969 and E-ISSN 1467-1131, this journal serves as a critical platform for researchers, clinicians, and students in oncology and radiology, providing vital insights into treatment methodologies, patient care, and innovative practices. Although indexed in Q4 quartiles for both Oncology and Radiology, Nuclear Medicine and Imaging, the journal plays an essential role in disseminating clinical findings and advancing the science of radiotherapy since its inception in 1999. Authors are encouraged to contribute their research, case studies, and reviews that align with the journal's objectives, fostering a collaborative environment for sharing knowledge. Despite its current rankings, the journal aims to enhance its impact and visibility in the scientific community, thereby enriching professional practice and patient outcomes in the realm of radiotherapy.

Radiation Oncology Journal, published by the Korean Society of Therapeutic Radiology & Oncology, stands at the forefront of cancer treatment research and innovation within the dynamic fields of oncology and radiology. With a focus on disseminating groundbreaking findings and advancements from 2012 to 2024, this journal aims to foster collaboration among researchers, clinicians, and educators dedicated to improving therapeutic techniques and patient outcomes in the context of radiation therapy. Recognized with a prestigious Q2 ranking in both the Oncology and Radiology, Nuclear Medicine and Imaging categories, it ranks 140th out of 333 in its Scopus category for Medicine Radiology and boasts a 58th percentile placement. While operating on a non-open access basis, the journal remains committed to providing valuable insights and updates to professionals in the field from its base in South Korea. As the landscape of cancer treatment evolves, the Radiation Oncology Journal continues to play a vital role in shaping research trends and enhancing the understanding of radiotherapy's role in comprehensive cancer care.

Ocular Oncology and Pathology is a distinguished journal dedicated to the multifaceted study of ocular diseases, particularly focusing on oncology and pathology. Published by KARGER, a reputable publisher based in Switzerland, this journal serves as a vital resource for researchers, clinicians, and students in the fields of ophthalmology, pathology, and oncology. With an ISSN of 2296-4681 and an E-ISSN of 2296-4657, the journal has established itself as a significant contributor to the literature, achieving a commendable ranking of 55th out of 139 in the General Nursing category within Scopus, placing it in the 60th percentile. Now converging its expertise until 2024, Ocular Oncology and Pathology aims to publish high-quality, peer-reviewed research articles that advance the understanding of ocular neoplasms and their pathological features. The journal’s commitment to open access promotes the dissemination of vital scientific knowledge, ensuring worldwide accessibility to high-impact research, making it an essential platform for the academic community.

Translational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.